Rolf Grempler,Thomas Klein,Michael Mark,Leo Seman,Leo Thomas
申请号：
US13637413
公开号：
US20140088027A1
申请日:
2011.03.28
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The invention relates to a pharmaceutical composition comprising an SGLT2 inhibitor and a PPARγ agonist which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
